Clinical trial

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

NCT07777575

Study summary

ClinicalTrials.gov

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Dual GIP/GLP-1 Receptor Agonist Tirzepatide Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Resistance Training Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-07

PhasePHASE4

Conditions

Obesity (BMI>30)unresolved

Interventions

Dual GIP/GLP-1 Receptor Agonist TirzepatideDRUG

Resistance TrainingBEHAVIORAL

Sponsors & collaborators

Technical University of Munichlead sponsor

EGYM SEcollaborator

Mapped research locations

MünchenBavaria, Germany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07777575 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.